Gaudium IVF IPO Day 3: Subscription Jumps 3.87x as Retail and NII Investors Stay Aggressive

Gaudium IVF IPO Day 3: Subscription Jumps 3.87x as Retail and NII Investors Stay Aggressive

The Gaudium IVF IPO Day 3 saw strong momentum building up as the issue was subscribed 3.87 times by 10:45 AM on its final day of bidding. Investor interest remained steady through the morning session.

Retail and non-institutional investors led the charge. Institutional participation, however, stayed limited.

Here’s a clear breakdown of what happened on Gaudium IVF IPO Day 3 and why the numbers matter.

Market Performance: Gaudium IVF IPO Day 3 Subscription Status

By mid-morning on Day 3, exchange data showed:

  • Total bids received: 5.65 crore shares
  • Total issue size: 1.46 crore shares
  • Overall subscription: 3.87 times

The demand pattern tells a simple story — strong interest from individual and high-ticket investors, cautious participation from institutions.

The Gaudium IVF IPO Day 3 numbers reflect solid traction in the public portion of the issue.

Open a free demat accountRetail Investors Push Subscription Higher

Retail participation remained a key driver.

  • Retail quota reserved: 73.10 lakh shares
  • Retail bids received: 3.63 crore shares
  • Retail subscription: 4.96 times

Within the retail segment:

  • Cut-off bids: 3.05 crore shares
  • Price bids: 57.61 lakh shares

Most retail bidders opted for the cut-off price. This usually indicates investors were willing to subscribe at the final discovered price within the band.

Retail demand staying near five times subscription on the last day shows steady interest rather than last-minute panic buying.

NII Segment Sees Strong Traction

The non-institutional investor category showed even stronger numbers.

  • Overall NII subscription: 6.42 times

Break-up within NII:

  • Small NII (₹2–10 lakh applications): 8.97 times
  • Big NII (above ₹10 lakh): 5.14 times

Small NII investors displayed the highest enthusiasm. The nearly 9x subscription in this segment reflects aggressive bidding in the mid-ticket category.

The Gaudium IVF IPO Day 3 momentum was clearly backed by this segment.

QIB Participation Remains Modest

Institutional participation remained limited.

  • QIB quota reserved: 41.77 lakh shares
  • Bids received: 1.19 lakh shares
  • Subscription level: 3%

Compared to retail and NII demand, QIB subscription stood much lower at the time of reporting.

This uneven demand pattern shaped the overall subscription mix on Day 3.

IPO Structure: Issue Size and Price Band

The Gaudium IVF IPO is a ₹165 crore book-built issue.

The issue comprises:

  • Fresh issue: ₹90 crore
  • Offer for Sale (OFS): ₹75 crore by promoter and founder Dr Manika Khanna

Price band: ₹75–₹79 per share

The issue closes for subscription later today.

Anchor Investor Participation Before IPO

Ahead of the public subscription, the company raised ₹49.5 crore from four anchor investors on February 19.

  • Shares allocated to anchors: 62.65 lakh
  • Allocation price: Upper end of price band

Anchor participation included:

  • Meru Investment Fund – Nearly ₹17 crore
  • Sanshi Fund – About ₹12.5 crore
  • Hornbill Orchid India Fund – ₹10 crore
  • Carnelian India Multi-Strategy Fund – ₹10 crore

This anchor placement happened before Gaudium IVF IPO Day 3, providing early institutional backing.

Company Details: Gaudium IVF and Women Health

Incorporated in 2015, Gaudium IVF is a New Delhi-based fertility services provider.

The company operates on a hub-and-spoke model.

Operational network includes:

  • 7 hubs across key markets:
    • Delhi
    • Mumbai
    • Punjab
    • Jammu and Kashmir
    • Bihar
    • Bangalore
  • 28 spoke centres through strategic alliances with infertility specialists

This expansion model allows centralised expertise while widening geographic reach.

Use of IPO Proceeds

The company has outlined planned utilisation of fresh issue funds:

  • ₹50 crore – Establishment of 19 new IVF centres
  • ₹20 crore – Repayment of certain outstanding loans
  • Remaining amount – General corporate purposes

Expansion and debt reduction form the key allocation areas.

Listing Timeline

As per the schedule:

  • Share allotment expected: February 25
  • Proposed listing date: February 27
  • Proposed exchanges: BSE and NSE

With Gaudium IVF IPO Day 3 closing today, the next key milestone will be the final subscription numbers and allotment process.

What Gaudium IVF IPO Day 3 Tells Us?

The data from Gaudium IVF IPO Day 3 shows a clear trend:

  • Retail investors showed strong participation.
  • Small NII applications were highly aggressive.
  • Institutional demand remained muted at the time of reporting.

Total bids crossed 5.65 crore shares against an offer of 1.46 crore shares, pushing overall subscription to 3.87 times.

The subscription pattern reflects differentiated investor participation across categories.

Summary of Gaudium IVF IPO Day 3

The Gaudium IVF IPO Day 3 closed with solid participation momentum through the morning session. Retail and NII investors drove the demand, with subscriptions of 4.96x and 6.42x respectively. Small NIIs stood out at 8.97x.

The issue size stands at ₹165 crore, with a price band of ₹75–₹79 per share. The company plans to use funds for expansion and loan repayment.

With allotment expected on February 25 and listing scheduled for February 27, market attention now shifts to final subscription data and debut performance.

For now, Gaudium IVF IPO Day 3 highlights strong public participation backed by numerical traction across retail and NII categories.

Source: Moneycontrol

Tagged:

Download the Samco Trading App

Get the link to download the app.

Samco Fast Trading App

Leave A Comment?